Read More

EXCLSUIVE: Hoth Therapeutics Says Enrollment And Dosing Has Begun For Second Cohort In First In-Human Clinical Trial Investigating Topical BioLexa For The Treatment Of Mild-To-Moderate Atomic Dermatitis

NEW YORK, NY November 30, 2021/ PR Newswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs, is pleased to

HOTH

Read More

EXCLUSIVE: Pasithea Therapeutics’ Wholly Owned Subsidiary Pasithea Clinics To Launch In-Home Intravenous Ketamine Therapy In New York City, Los Angeles, San Diego, And San Francisco To Expand Its International Footprint

Miami Beach, FL / November 17, 2021 -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and

KTTA

Read More

EXCLUSIVE: Tailwind Two Acquisition Corp. Announces Business Combo Deal With Small Satellites, Earth Observations Co., Terran Orbital, Pro Forma Enterprise Value $1.58B

IRVINE, CA. and BOCA RATON, FL. (October 28, 2021) — Tailwind Two Acquisition Corp. (NYSE: TWNT) (“Tailwind Two”), a special purpose acquisition company, and Terran Orbital Corporation, the global leaderIRVINE, CA. and BOCA RATON, FL. (October 28, 2021) — Tailwind Two Acquisition Corp.

TWNT

Read More

EXCLUSIVE: AgriFORCE Growing Systems Reports Binding Letter Of Intent To Buy Unnamed European Agricultural Technology Consultancy Firm For ~$29M In Cash, Stock

VANCOUVER, B.C. – October 27, 2021 – AgriFORCE Growing Systems Ltd. (“the Company") (NASDAQ:AGRI, AGRIW)), an IP-focused AgTech company dedicated to advancing sustainable cultivation andVANCOUVER, B.C. – October XX, 2021 – AgriFORCE Growing Systems Ltd.

AGRI